NCT04433832 is a clinical trial in Panic Disorder, sponsored by Laval University.

Who is sponsoring NCT04433832?

NCT04433832 is sponsored by Laval University.

What condition does NCT04433832 study?

NCT04433832 studies Panic Disorder, Generalized Anxiety Disorder, Coronary Artery Disease, Anxiety Disorders.

Is NCT04433832 still recruiting?

NCT04433832 is currently status unknown. Last updated 30 October 2020.

Last reviewed 2020-10-30 · How we verify

NCT04433832

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Physical and Psychological Health Trajectories in the Context of Coronary Heart Disease

Status unknown Last updated 30 October 2020

What this trial tests

trial in Panic Disorder in 3,610 participants. Status unknown.

Timeline

20 January 2020

Primary endpoint
30 June 2022

30 November 2023

Quick facts

Lead sponsor	Laval University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	3,610
Start date	20 January 2020
Primary completion	30 June 2022
Estimated completion	30 November 2023
Sites	1 location across Canada

Conditions studied

Panic Disorder — all drugs for Panic Disorder →
Generalized Anxiety Disorder — all drugs for Generalized Anxiety Disorder →
Coronary Artery Disease — all drugs for Coronary Artery Disease →
Anxiety Disorders — all drugs for Anxiety Disorders →

Sponsor

Laval University

Who can join

18 and older, any sex, with Panic Disorder or Generalized Anxiety Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of this study is to establish how frequently patients with coronary artery disease present or develop two anxiety disorders (panic disorder and generalized anxiety disorder) in the two years following a medical intervention for their heart. A second objective is to assess the impact of these anxiety disorders on the health of these patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Epidemiology and prognostic implications of panic disorder and generalized anxiety disorder in patients with coronary artery disease: rationale and design for a longitudinal cohort study.
Foldes-Busque G, Dionne CE, Turcotte S, Tully PJ, et al · · 2021 · cited 8× · PMID 33435888 · DOI 10.1186/s12872-021-01848-3

Verify or expand the search:

Other recruiting trials for Panic Disorder

Currently open trials in the same condition.

NCT06661460 — Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders · NA · recruiting
NCT06934525 — Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings · NA · recruiting
NCT07444879 — IL-33, sST2, and CRP in Panic Disorder · recruiting
NCT07024758 — Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolesce · NA · recruiting
NCT06942429 — Stepped Versus Stratified Care for Anxiety Disorders in Youth · NA · recruiting

Other Laval University trials

Trials by the same sponsor.

NCT07491887 — Identification of Objective Metabolomics-based Biomarkers of Yogurt Consumption · NA · not yet recruiting
NCT07366827 — Effectiveness of Motorised Lumbar Support for Non-specific Low Back Pain · NA · not yet recruiting
NCT07317973 — A Study About Patient Decision Aids Designed to Help Parents and Guardians in Canada Make Evidence-informed, Values-cong · NA · not yet recruiting
NCT07293312 — Optimizing the Use of Virtual Reality in Rehabilitation for Individuals With Persistent Shoulder Pain · NA · not yet recruiting
NCT07201870 — Digital Preparation for Bariatric Surgery: Feasability Pilot Trial · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04433832 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Laval University
Last refreshed: 30 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04433832.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing